Skip to main content
. 2016 Jul 19;2016(7):CD011461. doi: 10.1002/14651858.CD011461.pub2

2.2. Analysis.

2.2

Comparison 2 Molecular‐targeted therapy plus chemotherapy versus chemotherapy alone: Subgroup analysis according to the type of molecular‐targeted agents, Outcome 2 Progression‐free survival.